You just read:

Jazz Pharmaceuticals Submits Vyxeos™ Marketing Authorization Application to European Medicines Agency for Treatment of Certain Types of High-Risk Acute Myeloid Leukemia

News provided by

Jazz Pharmaceuticals plc

03 Nov, 2017, 12:30 GMT